Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

(2016) V. Kepenekian et al.   EUROPEAN JOURNAL OF CANCER

Pharmacokinetics and the effect of heat on intraperitoneal pemetrexed using a murine model

(2016) David Badrudin et al.   SURGICAL ONCOLOGY-OXFORD

Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy

(2016) Paul H. Sugarbaker et al.   Journal of Oncology Practice

Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience

(2015) Loïc Lang-Lazdunski et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis

(2015) Julien Hubert et al.   SURGICAL ONCOLOGY-OXFORD

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis

(2014) Joseph H. Helm et al.   ANNALS OF SURGICAL ONCOLOGY

Advances in malignant peritoneal mesothelioma

(2014) Shoubo Cao et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2013) Marcello Deraco et al.   ANNALS OF SURGICAL ONCOLOGY

Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy

(2013) Joshua C. Leinwand et al.   ANNALS OF SURGICAL ONCOLOGY

A Phase I Trial of Thermal Sensitization Using Induced Oxidative Stress in the Context of HIPEC

(2013) Lawrence E. Harrison et al.   ANNALS OF SURGICAL ONCOLOGY

Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

(2013) Deepa Magge et al.   ANNALS OF SURGICAL ONCOLOGY

Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)

(2013) Dario Baratti et al.   EUROPEAN JOURNAL OF CANCER

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

(2013) Lisa M. Landrum et al.   GYNECOLOGIC ONCOLOGY

Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy

(2013) Sébastien Gouy et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma

(2013) H. Richard Alexander et al.   SURGERY

Outcomes of cytoreduction with hyperthermic intraperitoneal chemotherapy: our experience at a midwest community hospital

(2012) Brent Goslin et al.   AMERICAN JOURNAL OF SURGERY

Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery)

(2012) D. Elias et al.   EJSO

Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: An in vitro evaluation

(2012) Robert B. Cameron et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis

(2011) François Quenet et al.   ANNALS OF SURGERY

Diffuse malignant peritoneal mesothelioma – An update on treatment

(2011) Peyman Mirarabshahii et al.   CANCER TREATMENT REVIEWS

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

(2010) Aaron U. Blackham et al.   ANNALS OF SURGICAL ONCOLOGY

A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*

(2010) Tristan D. Yan et al.   CANCER

Selection of patients and staging of peritoneal surface malignancies

(2010) Eddy Cotte   World Journal of Gastrointestinal Oncology

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005

(2009) Suresh H. Moolgavkar et al.   CANCER CAUSES & CONTROL

Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005

(2009) Bertram Price et al.   CRITICAL REVIEWS IN TOXICOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial

(2008) George R. Simon et al.   JOURNAL OF CLINICAL ONCOLOGY

The intraoperative staging systems in the management of peritoneal surface malignancy

(2008) A. Gomez Portilla et al.   JOURNAL OF SURGICAL ONCOLOGY

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: The Australian experience

(2008) Terence C. Chua et al.   JOURNAL OF SURGICAL ONCOLOGY

Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent

(2008) G. Carteni et al.   LUNG CANCER